Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pseudoefedrin 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
amoxicillin 1 g + kaliumklavulanat 62,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
diltiazem 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
trandolapril 2 mg + verapamilhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely valproate sodium 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
isosorbidmononitrat 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nisoldipine 10 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
kinidinglukonat 324 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Ibuprofen 800 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
etodolak 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
zolpidem 12,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
azatadinmaleat 1 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guajfenesin 600 mg + dextrometorfan 30 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
glipizid 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely mizolastine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
prokainamidhydroklorid 750 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
bupropionhydroklorid 50 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bezafibrate 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
takrolimus 1 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
oximorfon 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
lovastatin 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
bromfeniraminmaleat 16 mg + pseudoefedrinhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nifedipine 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
nisoldipin 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
karbidopa (som karbidopamonohydrat) 50 milligram och levodopa 200 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
naproxennatrium 200 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
ciprofloxacin 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Morphine sulfate 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely pyridostigmine bromide 180 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
vattenfritt teofyllin 450 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
trandolapril 4 mg + verapamilhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metoprololsuccinat 200 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 200 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
vattenfritt teofyllin 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metformin hydrochloride 750 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
karbinoxaminmaleat 8 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely valproate sodium 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Lithium carbonate 450 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
diltiazem 360 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
trandolapril 2 mg + verapamilhydroklorid 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
aminofyllin 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
ciprofloxacin 1 000 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely pentoxifylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely nifedipine 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 36 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
lovastatin 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
lovastatin 60 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
belladonnaalkaloider 0,2 mg + ergotamintartrat 0,6 mg + fenobarbital 40 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Isosorbide mononitrate 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
aminofyllin 225 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metamfetaminhydroklorid 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
naproxennatrium 220 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Methylphenidate hydrochloride 54 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metamfetaminhydroklorid 15 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
järn(II)sulfat 160 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely methylphenidate hydrochloride 27 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 75 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nisoldipine 20 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
oximorfon 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
desloratadin 5 mg + pseudoefedrin 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
verapamilhydroklorid 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metylfenidathydroklorid 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metoprololsuccinat 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Morphine sulfate 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
zolpidem 6,25 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely lithium carbonate 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
diltiazem 420 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Terbutaline sulfate 7.5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Diltiazem hydrochloride 60 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 30 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Diltiazem hydrochloride 90 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
oximorfon 20 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
aminofyllin 350 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pioglitazon 30 mg + metformin 1 g, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
enalaprilmaleat 5 mg + felodipin 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metformin hydrochloride 1 g prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|